{
  "ticker": "MDT",
  "companyName": "Medtronic plc",
  "industry": "Medical Devices",
  "sector": "Healthcare",
  "exchange": "NYSE",
  "lastUpdated": "2025-07-19",
  "currency": "USD",
  "currencyNote": "All financial data is in USD",
  "exchangeRate": {
    "usdToLocal": 1.0,
    "localToUsd": 1.0,
    "note": "Base currency is USD"
  },
  
  "marketData": {
    "currentPrice": 89.61,
    "currentPriceCurrency": "USD",
    "marketCap": 114810000000,
    "marketCapCurrency": "USD",
    "enterpriseValue": 135460000000,
    "sharesOutstanding": 1280000000,
    "beta": 0.82,
    "52WeekLow": 78.32,
    "52WeekHigh": 96.25,
    "priceTarget": 98.33,
    "analystRating": "Buy",
    "dataAsOf": "2025-07-18",
    "note": "Market data includes TTM financial metrics for most accurate valuation"
  },

  "riskFactors": {
    "riskFreeRate": 0.045,
    "marketRiskPremium": 0.06,
    "equityRiskPremium": 0.0828,
    "countryRiskPremium": 0.0,
    "smallCompanyPremium": 0.0,
    "specificRiskPremium": 0.01
  },

  "financialHistory": {
    "TTM": {
      "revenue": 33537000000,
      "grossProfit": 21931000000,
      "operatingIncome": 6403000000,
      "netIncome": 4662000000,
      "freeCashFlow": 5185000000,
      "operatingCashFlow": 7044000000,
      "capex": 1859000000,
      "totalAssets": 91680000000,
      "totalDebt": 29626000000,
      "cashAndEquivalents": 8965000000,
      "shareholdersEquity": 48256000000,
      "bookValuePerShare": 37.46,
      "eps": 3.61,
      "dividend": 2.84,
      "workingCapital": 10935000000,
      "totalEquity": 48256000000,
      "retainedEarnings": 31476000000,
      "period": "Trailing Twelve Months as of 2025-04-30",
      "reportingDate": "2025-04-30",
      "currency": "USD"
    },
    "2025": {
      "revenue": 33537000000,
      "grossProfit": 21931000000,
      "operatingIncome": 6403000000,
      "netIncome": 4662000000,
      "freeCashFlow": 5185000000,
      "operatingCashFlow": 7044000000,
      "capex": 1859000000,
      "totalAssets": 91680000000,
      "totalDebt": 29626000000,
      "cashAndEquivalents": 8965000000,
      "shareholdersEquity": 48256000000,
      "bookValuePerShare": 37.46,
      "eps": 3.61,
      "dividend": 2.80,
      "workingCapital": 10935000000,
      "totalEquity": 48256000000,
      "retainedEarnings": 31476000000,
      "currency": "USD"
    },
    "2024": {
      "revenue": 32364000000,
      "grossProfit": 21273000000,
      "operatingIncome": 6391000000,
      "netIncome": 3676000000,
      "freeCashFlow": 5200000000,
      "operatingCashFlow": 6787000000,
      "capex": 1587000000,
      "totalAssets": 89981000000,
      "totalDebt": 26047000000,
      "cashAndEquivalents": 8005000000,
      "shareholdersEquity": 50420000000,
      "bookValuePerShare": 38.29,
      "eps": 2.76,
      "dividend": 2.76,
      "workingCapital": 11146000000,
      "totalEquity": 50420000000,
      "retainedEarnings": 30403000000,
      "currency": "USD"
    },
    "2023": {
      "revenue": 31227000000,
      "grossProfit": 20605000000,
      "operatingIncome": 5569000000,
      "netIncome": 3758000000,
      "freeCashFlow": 4580000000,
      "operatingCashFlow": 6039000000,
      "capex": 1459000000,
      "totalAssets": 90948000000,
      "totalDebt": 25413000000,
      "cashAndEquivalents": 7959000000,
      "shareholdersEquity": 51665000000,
      "bookValuePerShare": 38.69,
      "eps": 2.82,
      "dividend": 2.72,
      "workingCapital": 12624000000,
      "totalEquity": 51665000000,
      "retainedEarnings": 30392000000,
      "currency": "USD"
    },
    "2022": {
      "revenue": 31686000000,
      "grossProfit": 21658000000,
      "operatingIncome": 6847000000,
      "netIncome": 5039000000,
      "freeCashFlow": 5978000000,
      "operatingCashFlow": 7346000000,
      "capex": 1368000000,
      "totalAssets": 90981000000,
      "totalDebt": 24984000000,
      "cashAndEquivalents": 10573000000,
      "shareholdersEquity": 52722000000,
      "bookValuePerShare": 39.49,
      "eps": 3.73,
      "dividend": 2.52,
      "workingCapital": 16879000000,
      "totalEquity": 52722000000,
      "retainedEarnings": 16849000000,
      "currency": "USD"
    },
    "2021": {
      "revenue": 30117000000,
      "grossProfit": 19762000000,
      "operatingIncome": 5490000000,
      "netIncome": 3606000000,
      "freeCashFlow": 4885000000,
      "operatingCashFlow": 6240000000,
      "capex": 1355000000,
      "totalAssets": 93083000000,
      "totalDebt": 27404000000,
      "cashAndEquivalents": 10817000000,
      "shareholdersEquity": 51602000000,
      "bookValuePerShare": 38.23,
      "eps": 2.66,
      "dividend": 2.32,
      "workingCapital": 14039000000,
      "totalEquity": 51602000000,
      "retainedEarnings": 28594000000,
      "currency": "USD"
    },
    "2020": {
      "revenue": 28910000000,
      "grossProfit": 18970000000,
      "operatingIncome": 5270000000,
      "netIncome": 3452000000,
      "freeCashFlow": 4680000000,
      "operatingCashFlow": 5985000000,
      "capex": 1305000000,
      "totalAssets": 89140000000,
      "totalDebt": 26200000000,
      "cashAndEquivalents": 9800000000,
      "shareholdersEquity": 49500000000,
      "bookValuePerShare": 36.80,
      "eps": 2.55,
      "dividend": 2.16,
      "workingCapital": 13500000000,
      "totalEquity": 49500000000,
      "retainedEarnings": 27200000000,
      "currency": "USD"
    }
  },

  "keyRatios": {
    "profitabilityRatios": {
      "grossMargin": 0.6539,
      "operatingMargin": 0.1909,
      "netMargin": 0.1390,
      "roe": 0.0951,
      "roa": 0.0441,
      "roic": 0.0518
    },
    "liquidityRatios": {
      "currentRatio": 1.85,
      "quickRatio": 1.20,
      "cashRatio": 0.70
    },
    "leverageRatios": {
      "debtToEquity": 0.61,
      "debtToAssets": 0.32,
      "interestCoverage": 8.78,
      "debtToEbitda": 3.15
    },
    "valuationRatios": {
      "peRatio": 24.82,
      "forwardPE": 16.14,
      "pbRatio": 2.39,
      "psRatio": 3.44,
      "evToEbitda": 14.86,
      "evToSales": 4.04,
      "pegRatio": 3.02,
      "priceToFcf": 22.14
    },
    "efficiencyRatios": {
      "assetTurnover": 0.37,
      "inventoryTurnover": 2.17,
      "receivablesTurnover": 5.15
    },
    "dataNote": "Ratios based on TTM data as of 2025-04-30"
  },

  "growthMetrics": {
    "revenueGrowth5Y": 0.0532,
    "epsGrowth5Y": 0.156,
    "fcfGrowth5Y": 0.0510,
    "dividendGrowth5Y": 0.0544,
    "dividendGrowthStreak": 49
  },

  "dividendInfo": {
    "currentAnnualDividend": 2.84,
    "currentAnnualDividendUSD": 2.84,
    "currentDividendYield": 0.0317,
    "payoutFrequency": "Quarterly",
    "payoutRatio": 0.7784,
    "dividendGrowthRate": 0.0144,
    "consecutiveYearsOfGrowth": 49,
    "buybackYield": 0.0303,
    "shareholderYield": 0.0620,
    "nextExDividendDate": "2025-09-26",
    "nextPaymentDate": "2025-10-10",
    "dividendPolicy": "Medtronic has a strong commitment to returning cash to shareholders through dividends and share repurchases",
    "aristocratStatus": true,
    "aristocratSince": 1976,
    "currencyNote": "Dividend payments are in USD",
    "recentDividendHistory": [
      {
        "year": 2025,
        "quarters": [
          {
            "quarter": "Q4",
            "exDate": "2025-09-26",
            "payDate": "2025-10-10",
            "amount": 0.71,
            "amountUSD": 0.71,
            "status": "upcoming"
          },
          {
            "quarter": "Q3", 
            "exDate": "2025-06-27",
            "payDate": "2025-07-11",
            "amount": 0.71,
            "amountUSD": 0.71,
            "status": "paid"
          },
          {
            "quarter": "Q2",
            "exDate": "2025-03-28", 
            "payDate": "2025-04-11",
            "amount": 0.70,
            "amountUSD": 0.70,
            "status": "paid"
          },
          {
            "quarter": "Q1",
            "exDate": "2024-12-27",
            "payDate": "2025-01-10",
            "amount": 0.70,
            "amountUSD": 0.70,
            "status": "paid"
          }
        ],
        "annualTotal": 2.81,
        "annualTotalUSD": 2.81
      },
      {
        "year": 2024,
        "quarters": [
          {
            "quarter": "Q4",
            "exDate": "2024-09-27",
            "payDate": "2024-10-11", 
            "amount": 0.70,
            "amountUSD": 0.70,
            "status": "paid"
          },
          {
            "quarter": "Q3",
            "exDate": "2024-06-28",
            "payDate": "2024-07-12",
            "amount": 0.70,
            "amountUSD": 0.70,
            "status": "paid"
          },
          {
            "quarter": "Q2",
            "exDate": "2024-03-21",
            "payDate": "2024-04-12",
            "amount": 0.69,
            "amountUSD": 0.69,
            "status": "paid"
          },
          {
            "quarter": "Q1",
            "exDate": "2023-12-19",
            "payDate": "2024-01-12",
            "amount": 0.69,
            "amountUSD": 0.69,
            "status": "paid"
          }
        ],
        "annualTotal": 2.78,
        "annualTotalUSD": 2.78
      }
    ],
    "dividendGrowthAnalysis": {
      "growthRate1Y": 0.0144,
      "growthRate3Y": 0.0220,
      "growthRate5Y": 0.0544,
      "growthRate10Y": 0.0510,
      "compoundAnnualGrowthRate": 0.0510,
      "averageAnnualIncrease": 0.0520,
      "consecutiveIncreases": 49,
      "lastCut": "Never",
      "sustainabilityScore": "High"
    },
    "dividendMetrics": {
      "earningsCoverage": 1.27,
      "freeCashFlowCoverage": 1.43,
      "debtServiceCoverage": 8.78,
      "dividendToFcfRatio": 0.70,
      "retentionRatio": 0.22,
      "sustainableDividendGrowth": 0.021,
      "impliedGrowthRate": 0.025
    },
    "peerComparison": {
      "industryAverageDividendYield": 0.025,
      "industryAveragePayoutRatio": 0.65,
      "industryAverageGrowthRate": 0.04,
      "relativeYieldRanking": "Above",
      "relativeGrowthRanking": "Below",
      "reliabilityRanking": "Excellent"
    }
  },

  "industryBenchmarks": {
    "averagePE": 22.0,
    "averagePB": 3.2,
    "averageROE": 0.12,
    "averageDebtToEquity": 0.55,
    "averageRevGrowth": 0.06,
    "averageDividendYield": 0.025
  },

  "assumptions": {
    "terminalGrowthRate": 0.025,
    "growthPeriodYears": 10,
    "fadeYears": 5,
    "taxRate": 0.1663,
    "reinvestmentRate": 0.35,
    "dividendGrowthRate": 0.03,
    "perpetualGrowthRate": 0.025,
    "dividendAssumptions": {
      "targetPayoutRatio": 0.75,
      "minimumPayoutRatio": 0.70,
      "maximumPayoutRatio": 0.80,
      "expectedDividendGrowth": 0.03,
      "conservativeDividendGrowth": 0.02,
      "optimisticDividendGrowth": 0.05,
      "sustainabilityThreshold": 0.80,
      "cyclicalAdjustment": false,
      "variableDividendPolicy": false,
      "shareRepurchasePriority": "Equal to dividend",
      "specialDividendPotential": false,
      "currencyHedging": false,
      "currencyNote": "No foreign exchange exposure for dividend payments"
    }
  },

  "businessSegments": {
    "cardiovascular": {
      "revenue": 12480000000,
      "operatingIncome": 2808000000,
      "description": "Implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac ablation products",
      "growthRate": 0.0549,
      "marketPosition": "Leading global position in cardiac rhythm management and structural heart"
    },
    "neuroscience": {
      "revenue": 9850000000,
      "operatingIncome": 2216000000,
      "description": "Brain and spine therapies including neurostimulation, neurosurgery, and specialty therapeutics",
      "growthRate": 0.0467,
      "marketPosition": "Market leader in neurostimulation and strong position in spine surgery"
    },
    "medicalSurgery": {
      "revenue": 8410000000,
      "operatingIncome": 1893000000,
      "description": "Surgical robotics, energy devices, ventilators, and patient monitoring solutions",
      "growthRate": -0.0140,
      "marketPosition": "Growing presence in surgical robotics and established position in energy devices"
    },
    "diabetes": {
      "revenue": 2760000000,
      "operatingIncome": 620000000,
      "description": "Insulin pumps, continuous glucose monitoring, and diabetes management solutions",
      "growthRate": 0.1073,
      "marketPosition": "Leading position in insulin pump therapy; planned spin-off as MiniMed"
    }
  },

  "geographicRevenue": {
    "unitedStates": {
      "revenue": 17170000000,
      "percentage": 0.512,
      "growthRate": 0.0367,
      "description": "Largest market with strong presence across all business segments"
    },
    "restOfWorld": {
      "revenue": 16370000000,
      "percentage": 0.488,
      "growthRate": 0.0358,
      "description": "International markets including Europe, Asia Pacific, and emerging markets"
    }
  },

  "competitivePosition": {
    "marketLeadership": "Global leader in medical technology with strong positions in cardiac devices, neurostimulation, and insulin pumps",
    "keyProducts": [
      "MiniMed insulin pumps",
      "Cardiac pacemakers and ICDs", 
      "Deep brain stimulation systems",
      "Surgical robotics platforms",
      "TAVR heart valves"
    ],
    "competitiveAdvantages": [
      "Extensive global distribution network and scale",
      "Strong R&D capabilities with robust innovation pipeline",
      "Diversified product portfolio across multiple medical specialties",
      "Long-standing relationships with healthcare providers",
      "Regulatory expertise and proven track record of FDA approvals",
      "Strong balance sheet enabling continued investment in growth"
    ],
    "risks": [
      "Regulatory changes and healthcare reimbursement pressures",
      "Intense competition from medical device companies and new entrants",
      "Product liability and recall risks",
      "Foreign exchange rate fluctuations",
      "Integration challenges from diabetes business spin-off",
      "Cybersecurity threats to connected medical devices"
    ]
  }
}
